| 000 | 01616 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515040721.0 | ||
| 264 | 0 | _c20070130 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0968-0896 | ||
| 024 | 7 |
_a10.1016/j.bmc.2006.07.053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPôças, Elisa S C | |
| 245 | 0 | 0 |
_aStructure-activity relationship of wedelolactone analogues: structural requirements for inhibition of Na+, K+ -ATPase and binding to the central benzodiazepine receptor. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cDec 2006 |
||
| 300 |
_a7962-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCatechols _xchemistry |
| 650 | 0 | 4 |
_aCoumarins _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xenzymology |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aLopes, Daniele V S | |
| 700 | 1 | _ada Silva, Alcides J M | |
| 700 | 1 | _aPimenta, Paulo H C | |
| 700 | 1 | _aLeitão, Fernanda B | |
| 700 | 1 | _aNetto, Chaquip D | |
| 700 | 1 | _aBuarque, Camilla D | |
| 700 | 1 | _aBrito, Flávia V | |
| 700 | 1 | _aCosta, Paulo R R | |
| 700 | 1 | _aNoël, François | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 14 _gno. 23 _gp. 7962-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2006.07.053 _zAvailable from publisher's website |
| 999 |
_c16530666 _d16530666 |
||